Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018.

Antimicrobial Resistance and Infection Control
Hector Felipe Garcia-JeldesAmrita Bharat

Abstract

To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.

References

May 26, 2011·Expert Review of Anti-infective Therapy·Kyle D BrizendineJohn W Baddley
Dec 17, 2014·Intensive Care Medicine·Arunaloke ChakrabartiDeepak Mendiratta
Dec 19, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Jan 27, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyAnup Ghosh
Apr 5, 2017·The Journal of Infectious Diseases·Latania K Logan, Robert A Weinstein
May 18, 2018·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·I S Schwartz, G W Hammond
Aug 8, 2018·Medical Mycology·Kaitlin ForsbergSnigdha Vallabhaneni
Aug 21, 2018·Emerging Infectious Diseases·Philipp P KohlerUNKNOWN Toronto Invasive Bacterial Diseases Network (TIBDN)
Sep 19, 2018·Emerging Infectious Diseases·Eleanor AdamsUNKNOWN Candida auris Investigation Workgroup
Oct 4, 2018·The New England Journal of Medicine·David W EyreKatie J M Jeffery
Oct 9, 2018·The Journal of Antimicrobial Chemotherapy·Snigdha VallabhaneniBrendan R Jackson
Jun 22, 2019·Emerging Infectious Diseases·Axel HamprechtUNKNOWN German Candida auris Study Group
Jul 17, 2019·Emerging Infectious Diseases·Nancy A ChowJacques F Meis
Aug 2, 2019·MMWR. Morbidity and Mortality Weekly Report·Richard B BrooksSnigdha Vallabhaneni
Oct 3, 2019·Journal of Fungi·Erik H VogelzangKarin van Dijk

❮ Previous
Next ❯

Citations

Jan 25, 2021·American Journal of Infection Control·Eric J EckboMarthe Charles
Aug 24, 2021·Global Pediatric Health·Nahed Abdel-Haq, Basim I Asmar
Dec 16, 2021·Medical Mycology·Domenica G De LucaAmrita Bharat

❮ Previous
Next ❯

Software Mentioned

Excel
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Yuman LeeSagar Viramgama
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Ilan S Schwartz, T C Dingle
© 2022 Meta ULC. All rights reserved